急性呼吸窘迫综合征中高迁移率族蛋白B1释放机制的研究进展
本文为综述,聚焦急性呼吸窘迫综合征(ARDS)中高迁移率族蛋白B1(HMGB1)的释放机制。HMGB1是一种高度保守的非组蛋白核蛋白,具有强促炎特性,是ARDS的炎症介质之一。多项研究证实HMGB1通过结合晚期糖基化终末产物受体(RAGE)、Toll样受体(TLR)等调控ARDS,并可显著增加ARDS病死率。但其释放机制尚不清楚,本文关注与JAK/STAT、NF-κB、Notch、炎症小体、TNF、MAPK、ROS、PPAR等信号或依赖通路相关的HMGB1释放过程。
要点
- HMGB1是ARDS的炎症介质之一,多项研究证实其通过结合RAGE、TLR等受体调控ARDS,并可显著增加ARDS病死率。
- HMGB1的释放机制尚不清楚,本文聚焦其释放过程与JAK/STAT、NF-κB、Notch、炎症小体、TNF、MAPK、ROS、PPAR等信号或依赖通路的关联。
- HMGB1为高度保守的非组蛋白核蛋白,具有强促炎特性。
研究设计与关键结果
- 本文为综述,聚焦ARDS中HMGB1的释放机制,指出HMGB1是ARDS的炎症介质之一,多项研究证实其通过结合RAGE、TLR等受体调控ARDS,并可显著增加ARDS病死率。
- HMGB1的释放机制尚不清楚,本文关注与JAK/STAT、NF-κB、Notch、炎症小体、TNF、MAPK、ROS、PPAR等信号或依赖通路相关的HMGB1释放过程。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
High mobility group protein B1 (HMGB1), a highly conversed non-histone nucleoproteins with strong pro-inflammatory property, is one of the inflammatory mediator of the acute respiratory distress syndrome (ARDS). Numerous studies have confirmed that HMGB1 regulates ARDS by binding to receptor for advanced glycation end product (RAGE), Toll-like receptor (TLR) and etc. And it can significantly increase the mortality of ARDS. But the mechanism of HMGB1 release is still unclear. This study focuses on the HMGB1 release progress, which connected with Janus kinases/signal transducer and activator of transcription (JAK/STAT), nuclear factor-κB (NF-κB), Notch, inflammasome, tumor necrosis factor (TNF), mitogen-activated protein kinase (MAPK), reactive oxygen species (ROS), peroxisome proliferator-activated receptor (PPAR) and other signaling or dependent pathways in ARDS.
参考来源
- Shu X, Fan S, Xu Y, et al. [Research progress on release mechanism of high mobility group protein B1 in acute respiratory distress syndrome]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34412765. doi:10.3760/cma.j.cn121430-20200421-00316
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。